Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST)

Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST)

Background: Neutralizing monoclonal antibodies (NMabs) are recognized for their efficacy against non-severe COVID-19. However, spike protein mutations may confer resistance. This study evaluates the effectiveness of favipiravir (FPV) versus NMabs in preventing severe COVID-19 in special populations....

Full description

Bibliographic Details
Main Authors: Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Thachanun Porntharukcharoen, Supamas Sirisreetreerux, Thitapha Thongchai, Kamonwan Soonklang, Nithi Mahanonda
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:Journal of Infection and Public Health
Subjects:
Favipiravir
COVID-19
SARS-CoV-2
Neutralizing monoclonal antibody
Sotrovimab
Casirivimab/ imdevimab
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034124002053

Internet

http://www.sciencedirect.com/science/article/pii/S1876034124002053

Similar Items